VeriMomIst sodium caproamphoacetate in der Schwangerschaft sicher?
No harmonised CLP reproductive classifications (no H360/H361) and no SCCS/CIR safety assessment indicating reproductive hazard for sodium caproamphoacetate; peer‑reviewed reproductive/toxicology studies specific to this CAS are not reported. As an amphoteric surfactant used topically, systemic absorption is expected to be low but measurable for adults, so exposure is scored as 1 (low). Sources searched: ECHA C&L (no harmonised classification), PubChem, CosIng, PubMed (no reproductive studies found).
Related ingredients
Frequently asked questions
- Ist sodium caproamphoacetate in der Schwangerschaft sicher?
- No harmonised CLP reproductive classifications (no H360/H361) and no SCCS/CIR safety assessment indicating reproductive hazard for sodium caproamphoacetate; peer‑reviewed reproductive/toxicology studies specific to this CAS are not reported. As an amphoteric surfactant used topically, systemic absorption is expected to be low but measurable for adults, so exposure is scored as 1 (low). Sources searched: ECHA C&L (no harmonised classification), PubChem, CosIng, PubMed (no reproductive studies found).
- Ist sodium caproamphoacetate während des Stillens sicher?
- No evidence of reproductive or lactation-specific toxicity and no harmonised classification; mechanism of reproductive/lactation toxicity not described in available databases. Low but measurable dermal exposure assumed for topical use (adult e=1). Sources: ECHA C&L, PubChem, CosIng, PubMed.
- Ist sodium caproamphoacetate sicher für Babyhaut?
- No infant-specific toxicology or developmental data located and no regulatory flags for reproductive/developmental hazard. Because infant skin has higher absorption potential, the exposure score is increased by +1 compared with adults (adult e=1 → infant e=2). Typical use as a mild amphoteric surfactant supports low intrinsic hazard but higher relative exposure in 0–3 yr olds. Sources: CosIng, PubChem, ECHA C&L, PubMed (no infant studies found).
- Wie bewertet VeriMom sodium caproamphoacetate?
- VeriMom bewertet sodium caproamphoacetate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu sodium caproamphoacetate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu sodium caproamphoacetate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.